Edgardo Quiñones, Unidad de Cuidados Intensivos Cardiovasculares, Clínica Imbanaco, Cali, Colombia
Diego F. Scarpetta, Unidad de Cuidados Intensivos Cardiovasculares, Clínica Imbanaco, Cali, Colombia
Viviana Rúa, Unidad de Cuidados Intensivos Cardiovasculares, Clínica Imbanaco, Cali, Colombia
Angie G. Otalvaro, Unidad de Cuidados Intensivos Cardiovasculares, Clínica Imbanaco, Cali, Colombia
Extracorporeal hemoadsorption, integrated into the VA ECMO circuit, is used to remove inflammatory mediators and toxins, improving stability in cases of severe sepsis. We present the case of a 67-year-old man with dilated cardiomyopathy, who underwent heart transplantation and simultaneously developed bacteremia and fungemia due to Lactobacillus casei and Candida albicans 24 hours after the procedure. He was treated with antibiotics and hemoadsorption (Oxyris®), associated with clinical improvement and reduced need for vasoactive/inotropic support. ECMO was discontinued after 48 hours, and the patient is progressing favorably in intensive rehabilitation, highlighting the importance of early intervention.
Keywords: Heart transplant. Hemoadsorption. VA ECMO. Bacteremia. Fungemia.